Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials

INTRODUCTION: This post hoc exploratory analysis examined the effects of ertugliflozin on liver enzymes in patients with type 2 diabetes mellitus (T2DM). METHODS: Data were pooled from seven randomized, double-blind VERTIS phase 3 trials that evaluated ertugliflozin (5 mg and 15 mg) versus non-ertug...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Silvina, Calle, Roberto A., Terra, Steven G., Pong, Annpey, Tarasenko, Lisa, Raji, Annaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376773/
https://www.ncbi.nlm.nih.gov/pubmed/32648108
http://dx.doi.org/10.1007/s13300-020-00867-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376773/
https://www.ncbi.nlm.nih.gov/pubmed/32648108
http://dx.doi.org/10.1007/s13300-020-00867-1

Ejemplares similares